In conclusion, the research on pregabalin as an augmentation therapy for resistant OCD allows us to expand our treatment options, providing personalized care that is both innovative and grounded in scientific evidence.

while PH94B is not yet available, its development is a testament to the ongoing advancements in mental health treatment.